Pure Global AI
ANVISA registration 82532910055Valid until Oct 29, 2034

NUCLEAR IMMUNOGLOBULIN M FOR HEPATITIS B VIRUS (ANTI-HBC IGM)

ANVISA Registration Number: 82532910055AUREUM COMERCIO DE PRODUTOS MEDICOS E DIAGNOSTICOS LTDADIA.PRO DIAGNOSTIC BIOPROBES SRLRisk Class IV
Verified
Device names
Technical name
NUCLEAR IMMUNOGLOBULIN M FOR HEPATITIS B VIRUS (ANTI-HBC IGM)
View exact technical-name matches →
PT: IMUNOGLOBULINA M NUCLEAR PARA VÍRUS DE HEPATITE B (ANTI-HBC IGM)
Commercial name
HBc IgM
View exact commercial-name matches →
Risk class
Class IV
Registration details
Registration Number
82532910055
Process Number
25351106930202401
CNPJ
45682834000162
Company information
Registration Holder
AUREUM COMERCIO DE PRODUTOS MEDICOS E DIAGNOSTICOS LTDA
Manufacturer
DIA.PRO DIAGNOSTIC BIOPROBES SRL
Manufacturing Country
Italy
PT: ITÁLIA
Dates and status
Publication Date
Oct 29, 2024
Validity
29/10/2034
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for NUCLEAR IMMUNOGLOBULIN M FOR HEPATITIS B VIRUS (ANTI-HBC IGM) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 82532910055 and manufactured by DIA.PRO DIAGNOSTIC BIOPROBES SRL. The registration is held by AUREUM COMERCIO DE PRODUTOS MEDICOS E DIAGNOSTICOS LTDA with validity until Oct 29, 2034.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.